Itqan Capital expects decline in Mouwasat’s Q2 2020 profit

23/06/2020 Argaam

 

Itqan Capital expects a drop in Mouwasat Medical Services Company’s (Mouwasat) utilization rates and profit in the second quarter of 2020, before normalizing in the third quarter of the year.

 

The impact of COVID-19 is expected to reflect more evidently in Q2 2020 results due to low utilization rates in April and May, the brokerage firm noted.

 

However, it maintained a positive outlook for the company, despite short term risks from COVID-19, as it is expected to weather the impact of lower footfall in Q2 2020.

 

Meanwhile, the essentiality of healthcare services, along with Mouwasat’s planned capacity expansion in H2 2020, will aid in fast top-line recovery. In addition, the expansion plans are also set to support top-line recovery in 2021.

 

Itqan Capital revised its recommendation to “overweight”, lowering the target price to SAR 101.5 from SAR 105.4 a share.

Itqan Capital-Mouwasat (23/6/2020)

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Most Read